Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study

NARecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
Stomach Neoplasms
Interventions
PROCEDURE

Surgery plus HIPEC CO2

Prophylactic surgery plus HIPEC CO2 performed with mitomycin and cisplatin v

PROCEDURE

Standard surgery

Standard surgery without HIPEC CO2

Trial Locations (13)

Unknown

ACTIVE_NOT_RECRUITING

IRCCS Istituto Tumori Giovanni Paolo II, Bari

ACTIVE_NOT_RECRUITING

AO Santa Croce e Carle, Cuneo

ACTIVE_NOT_RECRUITING

ULLS1 1 Dolomiti - Ospedale di Feltre, Feltre

ACTIVE_NOT_RECRUITING

Policlinico di Milano, Milan

ACTIVE_NOT_RECRUITING

A.O.R.N. A.Cardarelli, Napoli

ACTIVE_NOT_RECRUITING

Azienda Ospedaliera Universitaria Federico II, Napoli

ACTIVE_NOT_RECRUITING

Ospedale Evangelico Betania, Napoli

ACTIVE_NOT_RECRUITING

Azienda Ospedaliera S. Camillo Forlanini, Roma

ACTIVE_NOT_RECRUITING

Fondazione Policlinico Universitario A. Gemelli, Roma

RECRUITING

Fondazione Policlinico Universitario A. Gemelli, Roma

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli Irccs Universita' Cattolica Del Sacro Cuore, Roma

ACTIVE_NOT_RECRUITING

IRCCS Policlinico San Donato, San Donato Milanese

ACTIVE_NOT_RECRUITING

IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo

All Listed Sponsors
lead

Mario Negri Institute for Pharmacological Research

OTHER